A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

SmileDirectClub Announces Launch of Innovative SmileMaker Platform

Smile-Changing AI Technology Offers View of New Smiles Through Mobile Devices

SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the launch of its innovative SmileMaker Platform, making it easier than ever for consumers to get a smile they’ll love.

The first-generation SmileMaker Platform is available through the free SmileDirectClub App and leverages advanced Artificial Intelligence (AI) technology to show consumers their potential smile transformation within minutes. Consumers can download the SmileDirectClub App, which is compatible with Apple devices and coming soon to Android devices, and capture a 3D scan of their teeth, bite and alignment using their phone’s camera. This technology is an industry first, upgrading current 2D remote scanning options and introducing real-time AI to capture a 3D view of the teeth.

Just minutes after the 3D scan, consumers receive their “Custom Smile Plan” showing their potential new smile, along with an estimated time frame to achieve results, leveraging the Company’s treatment planning data from creating more than 1.8 million smiles. The SmileMaker Platform is part of the Company’s growing AI capabilities within its innovation portfolio, helping SmileDirectClub transform the oral care industry by making teeth straightening more accessible, convenient, and affordable.

“SmileDirectClub’s new SmileMaker Platform is a big step toward fulfilling our vision of creating smiles using leading-edge technology,” said David Katzman, CEO and Chairman, SmileDirectClub. “This is the brand’s first big innovation to come from our AI/Machine Learning Team and we look forward to continuing to improve the customer experience, better assist doctors, and increase access to oral care for more customers while keeping the costs of that care within reach for everyone.”

Following receipt of a Custom Smile Plan, customers will be prompted to provide further high-definition scans through the doctor-prescribed at-home impression kit or at a local SmileShop or Partner Network location. This information is uploaded into SmileDirectClub’s virtual care platform, along with the other information collected from customers, for review by the customer’s state-licensed treating dentist or orthodontist to determine candidacy for clear aligner therapy. Once approved, customers will be provided with a final treatment plan, their “Smile Prescription” to start their official smile journey.

“SmileMaker Platform puts game-changing technology in the palm of consumers’ hands, and this is just the beginning of what AI can do for the dental profession,” said Dr. Jeffrey Sulitzer, Chief Clinical Officer. “We revolutionized the industry with our virtual care model and will do so again with AI that improves the customer experience and better assists our affiliated network of dentists and orthodontists so they can focus on what they do best: providing quality care for their patients.”

The new platform is now available in Australia and will expand into the United States later this year or early 2023, followed by other international markets. Consumers in Australia can go to their Apple App Store today and begin their smile journey.

Since launching in the U.S. in 2014, SmileDirectClub has become one of the fastest-growing health technology companies, enabling care to more than 1.8 million customers around the world while saving them more than $5 billion collectively over the cost of traditional braces.*

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy